You need to enroll in this course to view this chapter
A Phase 2 Study of Ipatasertib in Combination w/ Pembrolizumab for 1st-line Treatment of Recurrent
0% Course Complete
A Phase 2 Study of Ipatasertib in Combination w/ Pembrolizumab for 1st-line Treatment of Recurrent Attachments
100%
Page 1 of ?/?
Go to:
Loading PDF...